nach oben

Erschienen in:

01.03.2012 | Original Research Paper

Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis

verfasst von: Luiz Felipe Domingues Passero, Ana Kely Carvalho, Maria Luiza A. C. Bordon, Alexis Bonfim-Melo, Marcos Hikari Toyama, Carlos Eduardo Pereira Corbett, Márcia Dalastra Laurenti

Erschienen in: Inflammation Research | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

Leishmania (Viannia) shawi was characterized only recently, and few studies concerning the immunogenic and protective properties of its antigens have been performed. The present study aimed to evaluate the protective potential of the five antigenic fractions isolated from L. (V.) shawi promastigotes in experimental cutaneous leishmaniasis.

Materials and methods

Soluble antigen from L. (V.) shawi promastigotes was submitted to reverse phase HPLC to purify F1, F2, F3, F4 and F5 antigens. BALB/c mice were immunized once a week for two consecutive weeks by subcutaneous routes in the rump, using 25 μg protein. After 1 week, groups were challenged in the footpad with L. (V.) shawi promastigotes. After 8 weeks, those same mice were sacrificed and parasite burden as well as the cellular and humoral immune responses were evaluated.

Results

F1 and F5-immunized mice restrained lesion progression and parasite load in the skin. However, only the F1 group was able to control the parasitism in lymph nodes, which was associated with low IL-4 and high IFN-γ production; IgG2a isotype was increased in this group. Immunizations with F2, F3 and F4 antigens did not protect mice.

Conclusion

The capability of antigens to restrain IL-4 levels and increase IFN-γ was associated with protection, such as in immunization using F1 antigen.

Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366:1561–1567.PubMedCrossRef

Bañuls AL, Hide M, Prugnolle F. Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv Parasitol. 2007;64:1–109.PubMedCrossRef

Lindoso JA, Lindoso AA. Neglected tropical diseases in Brazil. Rev Inst Med Trop Sao Paulo. 2009;51:247–253.PubMedCrossRef

Amato VS, Tuon FF, Bacha HA, Neto VA, Nicodemo AC. Mucosal leishmaniasis. Current scenario and prospects for treatment. Acta Trop. 2008;105:1–9.PubMedCrossRef

Silveira FT, Lainson R, De Castro Gomes CM, Laurenti MD, Corbett CE. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Parasite Immunol. 2009;31:423–431.PubMedCrossRef

Prajeeth CK, Haeberlein S, Sebald H, Schleicher U, Bogdan C. Leishmania-infected macrophages are targets of NK cell-derived cytokines, but not of NK cell cytotoxicity. Infect Immun. 2011;79:2699–2708. doi:10.1128/IAI.00079-11.

Ota H, Takashima Y, Matsumoto Y, Hayashi Y, Matsumoto Y. Pretreatment of macrophages with the combination of IFN-gamma and IL-12 induces resistance to Leishmania major at the early phase of infection. J Vet Med Sci. 2008;70:589–593.PubMedCrossRef

Aranha FC, Ribeiro U Jr, Basse P, Corbett CE, Laurenti MD. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection. Scand J Immunol. 2005;62:334–341.PubMedCrossRef

Launois P, Gumy A, Himmelrich H, Locksley RM, Röcken M, Louis JA. Rapid IL-4 production by Leishmania homolog of mammalian RACK1-reactive CD4(+) T cells in resistant mice treated once with anti-IL-12 or -IFN-gamma antibodies at the onset of infection with Leishmania major instructs Th2 cell development, resulting in nonhealing lesions. J Immunol. 2002;168:4628–4635.PubMed

10.

Himmelrich H, Launois P, Maillard I, Biedermann T, Tacchini-Cottier F, Locksley RM, Röcken M, Louis JA. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J Immunol. 2000;164:4819–4825.PubMed

11.

Strauss-Ayali D, Baneth G, Shor S, Okano F, Jaffe CL. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs. Int J Parasitol. 2005;35:63–73.PubMedCrossRef

12.

Jordan KA, Hunter CA. Regulation of CD8+T cell responses to infection with parasitic protozoa. Exp Parasitol. 2010;126:318–325.PubMedCrossRef

13.

Passero LFD, Marques C, Vale-Gato I, Corbett CE, Laurenti MD, Santos-Gomes G. Histopathology, humoral and cellular immune response in the murine model of Leishmania (Viannia) shawi. Parasitol Int. 2010;59:159–165.PubMedCrossRef

14.

Nateghi Rostami M, Keshavarz H, Edalat R, Sarrafnejad A, Shahrestani T, Mahboudi F, Khamesipour A. CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis. PLoS Negl Trop Dis. 2010;4:e845.PubMedCrossRef

15.

Ferreira JH, Gentil LG, Dias SS, Fedeli CE, Katz S, Barbiéri CL. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis. Vaccine. 2008;26:677–685.PubMedCrossRef

16.

Passero LF, Sacomori JV, Tomokane TY, Corbett CE, da Silveira FT, Laurenti MD. Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi. Parasitol Res. 2009;105:1741–1747.PubMedCrossRef

17.

Wanasen N, Xin L, Soong L. Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Int J Parasitol. 2008;38:417–419.PubMedCrossRef

18.

Silveira FT, Lainson R, Corbett CE. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. Mem Inst Oswaldo Cruz. 2004;99:239–251.PubMedCrossRef

19.

Souza-Lemos C, de-Campos SN, Teva A, Côrte-Real S, Fonseca EC, Porrozzi R, Grimaldi G Jr. Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta. J Pathol. 2008;216:375–386.PubMedCrossRef

20.

Novoa R, Bacellar O, Nascimento M, Cardoso TM, Ramasawmy R, Oliveira WN, Schriefer A, Carvalho EM. IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis infection. Parasite Immunol. 2011;33:132–136.PubMedCrossRef

21.

Guimarães ET, Santos LA, Ribeiro dos Santos R, Teixeira MM, dos Santos WL, Soares MB. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice. Microbes Infect. 2006;8:1219–1226.PubMedCrossRef

22.

De Luca PM, Mayrink W, Santiago MA, Nogueira R, Conceição-Silva F, Mélo G, Mendonça SC. Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test. Trans R Soc Trop Med Hyg. 2003;97:709–712.PubMedCrossRef

23.

Telino E, De Luca PM, Matos DC, Azeredo-Coutinho RB, Meirelles MN, Conceição-Silva F, Schubach A, Mendonça SC. In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes. Clin Exp Immunol. 2006;143:338–344.PubMedCrossRef

24.

Montalvo Alvarez AM, Nodarse JF, Goodridge IM, Fidalgo LM, Marin M, Van Der Auwera G, Dujardin JC, Bernal ID, Muskus C. Differentiation of Leishmania (Viannia) panamensis and Leishmania (V.) guyanensis using BccI for hsp70 PCR-RFLP. Trans R Soc Trop Med Hyg. 2010;104:364–367.PubMedCrossRef

25.

Corrêa JR, Brazil RP, Soares MJ. Leishmania (Viannia) lainsoni (Kinetoplastida: Trypanosomatidae), a divergent Leishmania of the Viannia subgenus—a mini review. Mem Inst Oswaldo Cruz. 2005;100:587–592.PubMedCrossRef

26.

Silveira FT, Ishikawa EA, De Souza AA, Lainson R. An outbreak of cutaneous leishmaniasis among soldiers in Belém, Pará State, Brazil, caused by Leishmania (Viannia) lindenbergi n. sp. A new leishmanial parasite of man in the Amazon region. Parasite. 2002;9:43–50.PubMed

27.

Shaw JJ, Ishikawa EA, Lainson R, Braga RR, Silveira FT. Cutaneous leishmaniasis of man due to Leishmania (Viannia) shawi Lainson, de Souza, Póvoa, Ishikawa & Silveira, in Pará State, Brazil. Ann Parasitol Hum Comp. 1991;66:243–246.PubMed

28.

Brito ME, Andrade MS, Mendonça MG, Silva CJ, Almeida EL, Lima BS, Félix SM, Abath FG, da Graça GC, Porrozzi R, Ishikawa EA, Shaw JJ, Cupolillo E, Brandão-Filho SP. Species diversity of Leishmania (Viannia) parasites circulating in an endemic area for cutaneous leishmaniasis located in the Atlantic rainforest region of northeastern Brazil. Trop Med Int Health. 2009;14:1278–1286.PubMedCrossRef

29.

Passero LFD, Bordon MLAC, Carvalho AK, Martins LM, Corbett CEP, Laurenti MD. Exacerbation of L. (V.) shawi infection after immunization with soluble antigen from amastigote forms. APMIS. 2010;118:973–981.PubMedCrossRef

30.

Toyama MH, Toyama DO, Passero LF, Laurenti MD, Corbett CE, Tomokane TY, Fonseca FV, Antunes E, Joazeiro PP, Beriam LO, Martins MA, Monteiro HS, Fonteles MC. Isolation of a new l-amino acid oxidase from Crotalus durissus cascavella venom. Toxicon. 2001;47:47–57.CrossRef

31.

Titus RG, Marchand M, Boon T, Louis JA. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 1985;7:545–555.PubMedCrossRef

32.

Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986;89:271–277.PubMedCrossRef

33.

Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods. 1986;94:57–63.PubMedCrossRef

34.

Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol. 1993;54:229–270.PubMedCrossRef

35.

Silveira FT, Lainson R, Gomes CM, Laurenti MD, Corbett CE. Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 2008;102:1075–1080.PubMedCrossRef

36.

Badovinac VP, Tvinnereim AR, Harty JT. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science. 2000;290:1354–1358.PubMedCrossRef

37.

Whitmire JK, Benning N, Whitton JL. Cutting edge: early IFN-gamma signaling directly enhances primary antiviral CD4+ T cell responses. J Immunol. 2005;175:5624–5628.PubMed

38.

Bhattacharyya S, Ghosh S, Jhonson PL, Bhattacharya SK, Majumdar S. Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events. Infect Immun. 2001;69:1499–1507.PubMedCrossRef

39.

Aseffa A, Gumy A, Launois P, MacDonald HR, Louis JA, Tacchini-Cottier F. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4 + CD25 + T cells. J Immunol. 2002;169:3232–3241.PubMed

40.

Xu D, Liu H, Komai-Koma M, Campbell C, McSharry C, Alexander J, Liew FY. CD4 + CD25 + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol. 2003;170:394–399.PubMed

41.

Holaday BJ, Pompeu MM, Jeronimo S, Texeira MJ, Sousa Ade A, Vasconcelos AW, Pearson RD, Abrams JS, Locksley RM. Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest. 1993;92:2626–2632.PubMedCrossRef

42.

Tabatabaee PA, Abolhassani M, Mahdavi M, Nahrevanian H, Azadmanesh K. Leishmania major: secreted antigens of Leishmania major promastigotes shift the immune response of the C57BL/6 mice toward Th2 in vitro. Exp Parasitol. 2011;127:46–51.PubMedCrossRef

43.

Silva VM, Larangeira DF, Oliveira PR, Sampaio RB, Suzart P, Biointervention Student Group, Nihei JS, Teixeira MC, Mengel JO, dos-Santos WL, Pontes-de-Carvalho L. Enhancement of experimental cutaneous leishmaniasis by Leishmania molecules is dependent on interleukin-4, serine protease/esterase activity, and parasite and host genetic backgrounds. Infect Immun. 2011;79:1236–1243.PubMedCrossRef

44.

Laabs EM, Wu W, Mendez S. Vaccination with live Leishmania major and CpG DNA promotes interleukin-2 production by dermal dendritic cells and NK cell activation. Clin Vaccine Immunol. 2009;16:1601–1606.PubMedCrossRef

45.

Joyee AG, Uzonna J, Yang X. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection. J Immunol. 2010;184:2095–2106.PubMedCrossRef

46.

Pereira LI, Dorta ML, Pereira AJ, Bastos RP, Oliveira MA, Pinto SA, Galdino H Jr, Mayrink W, Barcelos W, Toledo VP, Lima GM, Ribeiro-Dias F. Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG/Leishmania antigens. Am J Trop Med Hyg. 2009;81:378–383.PubMed

47.

Morris L, Troutt AB, McLeod KS, Kelso A, Handman E, Aebischer T. Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect Immun. 1993;61:3459–3465.PubMed

48.

Jones DE, Buxbaum LU, Scott P. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J Immunol. 2000;165:364–372.PubMed

49.

de Souza-Neto SM, Carneiro CM, Vieira LQ, Afonso LC. Leishmania braziliensis: partial control of experimental infection by interleukin-12 p40 deficient mice. Mem Inst Oswaldo Cruz. 2004;99:289–294.PubMedCrossRef

50.

Buxbaum LU, Uzonna JE, Goldschmidt MH, Scott P. Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur J Immunol. 2002;32:3206–3215.PubMedCrossRef

51.

Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA. Novel p19 protein engages IL-12p40 to form a cytokine, IL- 23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715–725.PubMedCrossRef

52.

Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, Blumenschein WM, Mattson JD, Wagner JL, To W, Zurawski S, McClanahan TK, Gorman DM, Bazan JF, de Waal Malefyt R, Rennick D, Kastelein RA. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity. 2002;16:779–790.PubMedCrossRef

Titel: Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis
verfasst von: Luiz Felipe Domingues Passero
Ana Kely Carvalho
Maria Luiza A. C. Bordon
Alexis Bonfim-Melo
Marcos Hikari Toyama
Carlos Eduardo Pereira Corbett
Márcia Dalastra Laurenti
Publikationsdatum: 01.03.2012
Verlag: SP Birkhäuser Verlag Basel
Erschienen in: Inflammation Research / Ausgabe 3/2012
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI: https://doi.org/10.1007/s00011-011-0407-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis

Abstract

Objective

Materials and methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Objective

Materials and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Severe neutrophil-mediated lung inflammation in myeloperoxidase-deficient mice exposed to zymosan

Study of dexamethasone, baicalin and octreotide on brain injury of rats with severe acute pancreatitis

TLR4 polymorphisms and disease susceptibility

The NLRP3 inflammasome is active but not essential in endotoxin-induced uveitis

A20 and ABIN-3 possibly promote regression of trehalose 6,6′-dimycolate (TDM)-induced granuloma by interacting with an NF-kappa B signaling protein, TAK-1

Anti-inflammatory effects of kaempferol-3-O-sophoroside in human endothelial cells

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin